Pharma Co. Can't Save Blood Pressure Drug Patent At EPO
A Hungarian pharmaceutical company has lost its European patent over a blood pressure drug after officials ruled in a decision published Wednesday that the company had unlawfully broadened its patent....To view the full article, register now.
Already a subscriber? Click here to view full article